A. Lujambio

Cancer Research · 2007–2021

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom A. Lujambio trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Lin He
  2. E. Miska
  3. Daiya Takai
  4. Rui Shi
  5. Manel Esteller
  6. George A. Calin
  7. Jun Lu
  8. Gregory J. Hannon
  9. D. Hanahan
  10. Peter A. Jones

Who trusts A. Lujambio overall

  1. Manel Esteller
  2. Anna Portela
  3. Carlo Maria Croce
  4. Marilena V. Iorio

Papers from A. Lujambio's perspective

Ordered by how strongly the researchers A. Lujambio trusts endorse each paper. Same corpus, a different order for every researcher.

  1. MicroRNAs: small RNAs with a big role in gene regulation (Nature reviews genetics)
  2. Impaired microRNA processing enhances cellular transformation and tumorigenesis (Nature Genetics)
  3. microRNAs join the p53 network — another piece in the tumour-suppression puzzle (Nature Reviews. Cancer)
  4. A microRNA expression signature of human solid tumors defines cancer gene targets (Proceedings of the National Academy of Sciences of the United States of America)
  5. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. (Genes & Development)
  6. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. (Proceedings of the National Academy of Sciences of the United States of America)
  7. microRNAs exhibit high frequency genomic alterations in human cancer. (Proceedings of the National Academy of Sciences of the United States of America)
  8. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging (Proceedings of the National Academy of Sciences of the United States of America)
  9. How microRNAs control cell division, differentiation and death. (Current Opinion in Genetics and Development)
  10. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. (Cancer Cell)

Their papers